Advertisement
Home Blog Page 1500
FDA Authorizes Use of Monoclonal Antibody Treatment for COVID-19

FDA Advisory Committee OKs Pfizer-BioNTech COVID-19 Vaccine

0

Committee recommends emergency use authorization of the vaccine; vaccine to be distributed within 24 hours of EUA

Menopause Symptoms Reduced With Higher Levels of Exercise After Cancer Tx

0

Findings seen for women previously treated with menopause-inducing cancer treatments

Un antidepresivo podría ayudar a prevenir una COVID-19 grave

Neurologic Complications of COVID-19 Described

0

Most common neurologic findings in patients hospitalized for COVID-19 include altered mental status, fatigue, headache, stroke

CDC: 26.4 Percent of U.S. Adults With Diabetes Meet ABCS Goals

Risk Factors for Severe COVID-19 Up in Cancer Survivors

0

Cancer survivors also have increased risk for influenza hospitalization/death compared with cancer-free controls

¿Quiénes son los estadounidenses más solitarios? La respuesta podría sorprenderle

Deaths Up During Pandemic for Those With Rare Autoimmune Disorders

0

Individuals with rare autoimmune rheumatic diseases have prominently increased risk for death versus general population

HealthDay Reports: Coronavirus Has Killed Thousands at US Nursing Homes

Kidney Disease Leading Risk Factor for COVID-19 Hospitalization

0

COVID-19 patients with end-stage renal disease 11 times more likely to be hospitalized versus patients with no kidney disease

Broader Genetic Testing Could ID More Heritable Cancers

ASH: CRISPR-Cas9 Gene Editing Promising in TDT, SCD

0

Total hemoglobin, fetal Hb increased in five patients with transfusion-dependent ß-thalassemia, two with sickle cell disease

Routine COVID-19 Testing Improves Safety of Elective Surgery

FDA Authorizes First OTC COVID-19 Home Test Collection Kit

0

Last week, the agency also authorized an at-home test collection kit for COVID-19 and flu, available by prescription

ED Visits for Peds Asthma Plunged Under COVID-19 Lockdown

0

Rate of emergency department visits decreased 80 and 82 percent in 2020 versus previous two years for week starting March 22

Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC

Genetic Ancestry Tied to Lung Cancer Mutations in Latin Americans

0

Mutation frequencies of EGFR and KRAS were 30 and 10 percent, respectively, and 23 and 13 percent, respectively, for Mexican and Colombian patients